Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
224,551,519
-
Share change
-
+14,851,261
-
Total reported value
-
$4,237,141,822
-
Put/Call ratio
-
38%
-
Price per share
-
$18.87
-
Number of holders
-
264
-
Value change
-
+$343,848,874
-
Number of buys
-
167
-
Number of sells
-
97
Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) as of Q2 2023
As of 30 Jun 2023,
IMMUNOGEN INC - COMMON STOCK (IMGN) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
224,551,519 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Point72 Asset Management, L.P., STATE STREET CORP, D. E. Shaw & Co., Inc., Fairmount Funds Management LLC, and FMR LLC.
This page lists
264
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.